{"id":"W2161676909","doi":"10.3747/co.19.949","title":"Response to Second-Line Erlotinib in an EGFR Mutation-Negative Patient with Non-Small-Cell Lung Cancer: Make No Assumptions","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Erlotinib; Medicine; Epidermal growth factor receptor; Lung cancer; Oncology; EGFR inhibitors; Mutation; Tyrosine-kinase inhibitor; Internal medicine; Cancer research; Erlotinib Hydrochloride; Biomarker; Tyrosine kinase; Gefitinib; Cancer; Gene; Receptor; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003065394,0.0003814128,0.0009686706,0.0005581668,0.0006500063,0.001365925,0.001523109,0.004768653,0.001200924],"category_scores_gemma":[0.009814747,0.0002242098,0.0009114218,0.0003088682,0.001432688,0.002188865,0.0005140462,0.002832022,0.0007429467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009100114,"about_ca_system_score_gemma":0.0004322106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004450869,"about_ca_topic_score_gemma":0.0005845017,"domain_scores_codex":[0.9986835,0.0003800356,0.0002896543,0.0001925049,0.0002430266,0.0002112568],"domain_scores_gemma":[0.9952232,0.003339049,0.0004300132,0.0003120921,0.0003995444,0.0002959482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00408938,0.0004656194,0.3307789,0.000452017,0.0003248923,0.5457972,0.001362685,0.002049926,0.009187657,0.00327587,0.01212038,0.09009537],"study_design_scores_gemma":[0.000480182,0.002197521,0.1358524,0.0007267264,0.0006134825,0.7978002,0.004244728,0.01226164,0.008199308,0.01225596,0.02517621,0.000191499],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8292367,0.0183225,0.003511383,0.1299449,0.00185897,0.0001047843,0.0002283727,0.00009774868,0.01669455],"genre_scores_gemma":[0.987799,0.002043114,0.0007386191,0.006457831,0.00217816,0.00001566393,0.00008330739,0.00001338226,0.0006708447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004768653,"threshold_uncertainty_score":0.01621151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04870029174905834,"score_gpt":0.4237004489221756,"score_spread":0.3750001571731173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}